The Numbers

The company grew 20% in 1Q23 due to improving procedure volumes, competitive rep recruiting and robotic pull-through.

Globus Starts 2023 with Momentum

The company grew 20% in 1Q23 due to improving procedure volumes, competitive rep recruiting and robotic pull-through.

According to our estimates, the global orthopedic market exceeded $55 billion in sales in 2022, driven by procedure volume improvement.

Chart of the Month: Market Exceeds $55b in 2022

According to our estimates, the global orthopedic market exceeded $55 billion in sales in 2022, driven by procedure volume improvement.

New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement.

3 Market Trends in Joint Replacement

New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement.

Orthonika Awarded Grant to Support Total Meniscus Replacement

The grant will help complete pre-clinical development and testing of a synthetic total meniscus replacement in preparation for the clinic.

,
Artelon Secures Funding to Advance Treatment of Joint Instability

The financing will fund commercial growth, clinical research, and expansion of Artelon’s product line for surgical treatment of ankles and other joints.

,
Bioventus Looks to Regain Credibility With Investors

The company’s 1Q23 orthopedic sales declined slightly as Bioventus embarks upon a quarters-long turnaround.

,
Monogram Orthopaedics Closes Public Offering

Monogram Orthopaedics commenced trading on NASDAQ under the ticker symbol MGRM.

,
Anika Therapeutics Sees Traction From Recent Launches

The company grew its orthopedic business 9% in 1Q23, driven by favorable order timing and contributions from new products.

,
Treace Medical Strengthens Position in Underserved Market

The company grew over 45% in 1Q23 as it further penetrates the large, underserved bunion surgical procedure market.

,
Paragon 28 Remains Cautious Despite Hot Start to FY23

The company grew 26% in 1Q23 against strong comps than most of the orthopedic industry, but opted to not increase it revenue guidance.

,
Orthofix Completes First Quarter as Combined Company

The company grew 11.1% on a pro forma basis in 1Q23, driven by strength across its businesses and no major dissyngeries from the merge

,
OrthoPediatrics Off To Better Than Expected Start for FY23

The company grew more than 30% in the first quarter of 2023 despite ongoing staffing challenges at pediatric hospitals.

,
Globus Starts 2023 with Momentum

The company grew 20% in 1Q23 due to improving procedure volumes, competitive rep recruiting and robotic pull-through.

,
Conformis Customers Slow to Embrace New Business Model

The company’s 1Q23 sales declined in the high teens as its business model shift and operational challenges take a toll.

,
Enovis Rides Momentum from Scaling Acquisitions

The company grew in the high teens in 1Q23 due to easing market pressures in the U.S. and some international markets in “overdrive.”

,
ATEC Positions for Informatics Arms Race

The company grew 54% in 1Q23 and acquired the REMI navigated robotics system as ATEC prepares for the modernization of spine surgery.

,
Zimmer Biomet Takes Advantage of Easing Market Pressure

The company grew in the low double-digits for 1Q23, driven by easier comps from the prior year, easing market pressure and new products.

,
ZimVie Rounding Corner on Spine Turnaround

The company’s spine business declined in the high-single-digits in 1Q23 but will benefit from more commercial focus in 2023.

,

Contact Us

0